MSK Cancer Center — New York, New York

MSK Cancer Center is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

MSK Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma.

Sponsors: Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MSK Cancer Center?

MSK Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MSK Cancer Center conducted?

MSK Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma.

Is MSK Cancer Center accredited by Crixeo Health?

MSK Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MSK Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.